SCHEMBL6168002

SCHEMBL6168002

Cc1onc(-c2ccc(C#N)cc2)c1-c1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.72
PTGS1 P23219 4/20 0.72
CA12 O43570 3/20 0.72
CA1 P00915 3/20 0.72
CA2 P00918 3/20 0.72
CA9 Q16790 3/20 0.72
MT-CO2 P00403 3/20 0.72
LMNA P02545 1/20 0.72
CA3 P07451 1/20 0.72
ADRB2 P07550 1/20 0.72
ADRB1 P08588 1/20 0.72
CYP3A4 P08684 1/20 0.72
ADORA3 P0DMS8 1/20 0.72
CHRM1 P11229 1/20 0.72
ADRA2B P18089 1/20 0.72
CA4 P22748 1/20 0.72
CA6 P23280 1/20 0.72
SLC6A2 P23975 1/20 0.72
PDE4A P27815 1/20 0.72
ADORA1 P30542 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170420 0.85 PTGS2 (0.82) PTGS2PTGS1CA12CA1CA2
SCHEMBL6168344 0.84 PTGS2 (1.00) PTGS2PTGS1CA12CA1CA2
Valdecoxib SCHEMBL3356 0.84 PTGS2 (1.00) PTGS2PTGS1CA12CA1CA2
Valdecoxib SCHEMBL3853130 0.84 PTGS2 (1.00) PTGS2PTGS1CA12CA1CA2
SCHEMBL4888365 0.83 PTGS2 (0.78) PTGS2PTGS1CA12CA1CA2
SCHEMBL14267686 0.83 PTGS2 (1.00) PTGS2PTGS1CA12CA1CA2
Valdecoxib SCHEMBL5999213 0.83 PTGS2 (0.97) PTGS2PTGS1CA12CA1CA2
Valdecoxib SCHEMBL6601157 0.83 PTGS2 (0.97) PTGS2PTGS1CA12CA1CA2
SCHEMBL7799111 0.83 PTGS2 (0.78) PTGS2PTGS1CA12CA1CA2
SCHEMBL4800858 0.83 PTGS2 (1.00) PTGS2PTGS1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5985902-A TREATING INFLAMMATION AND INFLAMMATION-ASSOCIATED DISORDERS, SUCH AS ARTHRITIS G.D. SEARLE & CO. (US) 1999-11-16 US disclosed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
US-5633272-A Substituted isoxazoles for the treatment of inflammation PHARMACIA & UPJOHN COMPANY LLC 1997-05-27 US disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed